The incidence and prevalence of prostate cancer is increasing. A numbe
r of aetiological factors including age, race, family history and diet
have been implicated. The majority of patients present with disease w
hich is amenable only to palliation. Digital rectal examination, serum
prostate-specific antigen and transrectal ultra-sound can lead to a p
rostatic biopsy. Transrectal ultrasound, magnetic resonance imaging, b
one scan and a chest X-ray are used for staging. The management of loc
alised cancer is shrouded in uncertainty. Three options exist, watchfu
l waiting, radiotherapy, and radical total prostatectomy. The publishe
d data are inadequate for a valid comparison of these, and none has be
en shown to offer an advantage. Surgery, and to a lesser degree radiot
herapy, have a significant morbidity. It is hoped that through better
understanding our management of this disease will improve.